Blog Archive 2017-12-20T16:25:47+00:00

Gene Therapy Milestones: Gilead’s Acquisition of Kite Pharma and FDA’s Novartis CAR-T Approval Signal an Advancing Gene Therapy Field; What Are Key Takeaways for Gene Therapy Companies?

September 1st, 2017|

By Nancy Bradish Myers, Anne McNickle and Jill Hartzler Warner In the past week, we’ve seen significant advances in the gene therapy world. Within the span of two days, Gilead announced it [...]

CRISPR Technology: Experts Explore Key Opportunities and Challenges in Catalyst-Moderated Panel

June 27th, 2017|

By Nancy Bradish Myers At the DIA annual meeting earlier this month, I had the privilege of exploring key regulatory issues related to CRISPR, as moderator of a session entitled “CRISPR: Regulatory [...]